AtaiBeckley Inc. (Eli Lilly subsidiary)

Logo
founded date:
2018
bitcoin only:
No
market valuation:
US$3.8B consideration
ceo:
Srinivas Rao
founders:
Angermayer, Brand, Rao, Wilde
key leadership:
Management resigned post-acquisition
lead investors:
Apeiron, Peter Thiel
total invested capital:
US$350M
subsidiaries:
Operating development entities
founder pedigree:
Biotech scientists
btc holdings:
58 BTC
btc yield per share:
N/A
infra overview:
Clinical-stage neuropsychiatric R&D
primary business revenue:
Clinical-stage (no revenue)
revenue activities:
Research and licensing
official email:
IR@ataibeckley.com
contact phone:
+1 332-282-0507
contact address:
250 West 34th Street, New York, NY
x handle: